NuCare Pharmaceuticals Inc recalls Valsartan/HCTZ 160/12.5 mg Tablets, 90-count jar, Rx Only, Packaged by NuCare Pharmaceuticals, Inc., Orange, CA 92867, N
Recalled August 15, 2018 · FDA recall D-1037-2018 · NuCare Pharmaceuticals
Hazard
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product. · FDA Class II
Units
N/A
Sold at
Distributed to three customers in Fl and CA
Description
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Product
Valsartan/HCTZ 160/12.5 mg Tablets, 90-count jar, Rx Only, Packaged by NuCare Pharmaceuticals, Inc., Orange, CA 92867, NDC 68071-4311-9
Manufacturer(s)
NuCare Pharmaceuticals Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →